BioCatalystWatch
FBIOWorkspace / FBIO / OverviewCompany library
Fortress Biotech, Inc. logo

Fortress Biotech, Inc.

Fortress Biotech, Inc. (FBIO)

Website

Price
Market cap
Next catalystExpected 2026FB-606 · Trial initiationCompany presentation ↗
Cash

Chart & Events

Candle interval

Core Clinical

ATX-04 (clenbuterol)

β2-adrenergic receptor

Upcoming / outlook

Triplex

CMV pp65 (UL83) × CMV IE1 (UL123) × CMV IE2 (UL122)

PreINDP1P2P3FilingApproved
Upcoming / outlook

IL13Rα2

PreINDP2P3FilingApproved

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

ATX-04 (clenbuterol)

β2-adrenergic receptor

Upcoming / outlook

Triplex

CMV pp65 (UL83) × CMV IE1 (UL123) × CMV IE2 (UL122)

PreINDP1P2P3FilingApproved
Upcoming / outlook

IL13Rα2

PreINDP2P3FilingApproved

Other pipelines

Triplex

CMV pp65 (UL83) × CMV IE1 (UL123) × CMV IE2 (UL122)

PreINDP1P2P3FilingApproved
Triplex

CMV pp65 (UL83) × CMV IE1 (UL123) × CMV IE2 (UL122)

MB-101

IL13Rα2

PreINDP1P2P3FilingApproved
IV tramadol

μ-opioid receptor

PreINDP1P2P3FilingApproved
ONCOlogues

Mutant DNA sequence

PreINDP1P2P3FilingApproved

Partner / License out

GABAA α2 receptor × GABAA α3 receptor

Approved

PreINDP1P2P3FilingApproved

Light-chain amyloid fibrils

PreINDP1P2P3FilingApproved

URAT1

PreINDP1P2P3FilingApproved
Upcoming / outlook

URAT1

PreINDP1P2P3FilingApproved
Upcoming / outlook

Approved / commercial

Approved

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

History / paused

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

FBIO SEC archive